- $1.71bn
- $1.34bn
- $45.95m
U.S. RESEARCH ROUNDUP-Cogent Communications, Dollar Tree, Home Depot
Septerna, Inc. reports results for the quarter ended June 30 - Earnings Summary
Septerna Q2 revenue beats analyst estimates, driven by Novo Nordisk partnership
Septerna Q1 revenue rises sharply helped by Novo Nordisk collaboration
Biotech firm Septerna beats Q4 revenue expectations, net loss narrows
Brief: Septerna Says SEP-631 Well-Tolerated With Adverse Event Profile Comparable To Placebo
U.S. STOCKS ON THE MOVE-Under Armour, GE Vernova, Walmart
U.S. STOCKS ON THE MOVE-Molina Healthcare, Memory chip makers, Binah Capital
U.S. STOCKS ON THE MOVE-Quantum, Septerna, Tripadvisor
Septerna rises after Wells Fargo upgrades to 'overweight'
Brief: Septerna Appoints Keith Gottesdiener, M.D., To Its Board Of Directors
U.S. STOCKS ON THE MOVE-DoorDash, Accenture, KB Home
Septerna up after H.C. Wainwright starts coverage with 'buy'
U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment
U.S. STOCKS ON THE MOVE-AbbVie, Millrose Properties, European Wax Center
U.S. STOCKS ON THE MOVE-PVH, chip companies, MP Materials
Septerna soars on $2.2 billion Novo Nordisk deal
Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments
U.S. RESEARCH ROUNDUP-Applied Materials, KLA, Oxford Industries